SCHEMBL19049586

SCHEMBL19049586

O=[N+]([O-])c1cc(C(F)(F)F)ccc1NCc1ccc2c(c1)OCCCO2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.54
▸ MEN1 O00255 4/20 0.54
▸ CRHBP P24387 1/20 0.53
▸ CRHR2 Q13324 1/20 0.53
▸ MAPT P10636 10/20 0.52
▸ MAPK1 P28482 3/20 0.52
▸ RAB9A P51151 2/20 0.50
▸ PKM P14618 1/20 0.48
▸ GAA P10253 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ STAT3 P40763 1/20 0.45
▸ LMNA P02545 3/20 0.45
▸ HTT P42858 2/20 0.43
▸ ALOX12 P18054 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19002761 0.82 KMT2A (0.57) KMT2AMEN1CRHBPCRHR2MAPT
SCHEMBL13331971 0.77 GAA (0.55) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL7335661 0.77 MAPT (0.63) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL13528776 0.77 MAPT (0.65) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL7170328 0.74 MAPT (0.57) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL15717116 0.73 GAA (0.53) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL28631373 0.73 MEN1 (0.43) KMT2AMEN1CRHBPCRHR2MAPT
SCHEMBL17152741 0.72 MAPT (0.50) KMT2AMEN1MAPTMAPK1RAB9A
SCHEMBL22288574 0.72 MAPT (0.50) KMT2AMEN1MAPTMAPK1RAB9A
Phosphonic Acid SCHEMBL27298727 0.72 MAPT (0.58) KMT2AMEN1MAPTMAPK1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017112777-A1 COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE SHY Therapeutics LLC (US) 2017-06-29 — — WO disclosed
Send feedback